Due to shortages beyond our control, our office has temporarily suspended our monoclonal antibody therapy service. We apologize for the inconvenience and we hope to have this resolved in the immediate future.
What Are Monoclonal Antibodies?
Monoclonal antibodies are among the most promising treatments for mild to moderate COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. Monoclonal antibodies are just like your body’s antibodies but selected for their strong ability to resist the virus. They are produced like a medication and help your body fight illness. In 2020, the Food and Drug Administration issued an emergency use authorization to permit monoclonal antibodies as a treatment option for COVID-19.
Who is Eligible for Monoclonal Antibody Treatment?
Anyone who tested positive for COVID-19, has had symptoms for 10 days or less, and one of the following:
- Be at least 65 years old
- Have a BMI of more than 25 kg/m2, or if age 12-17, have BMI above the 85th percentile for their age and gender based on CDC growth charts
- Currently Pregnant
- Have a medical condition, including:
- Chronic kidney disease
- Cardiovascular disease (including congenital heart disease, hypertension)
- Down syndrome
- Liver disease
- Chronic lung disease (ex. COPD)
- Sickle cell disease
- Immunosuppressive disease or immunosuppressive treatment
- History of stroke or cerebrovascular disease
- Current or history of substance abuse
- Neurodevelopmental disorders or other conditions that confer medical complexity
- Have a medical-related technological dependence (e.g., tracheostomy, gastrostomy)
Note: Monoclonal antibody treatment needs to be given within 10 days of the start of symptoms.